Monthly Archives: September 2011
JAAPA: When the Patient Asks – Can I be Screened for Ovarian Cancer
The JAAPA published a When the Patient Asks column on screening for ovarian cancer. WHO TO SCREEN High-risk women with a genetic mutation or strong family history should be screened. Routine transvaginal and pelvic ultrasonography with a CA-125 test may … Continue reading
Fluorescent Light Helps Doctors Identify Ovarian Cells
Doctors have used a special dye to track tumors during surgery. The dye makes ovarian cancer cells glow under fluorescent light. The study had 10 ovarian cancer patients, and may allow doctors to see tumors 30 times smaller than those they … Continue reading
Update on Ovarian Cancer Drug Shortages
Drug shortages continue to affect ovarian cancer patients in the United States. The Ovarian Cancer National Alliance has been tracking this issue closely and working with stakeholders and patients to identify solutions. We will continue to update our community as … Continue reading
Posted in Blog Leave a comment
National Hereditary Breast and Ovarian Cancer Week
September 25-October 2 is National Hereditary Breast and Ovarian Cancer week. Did you know there is a connection between hereditary ovarian and breast cancer? Approximately one out of every ten ovarian cancers is hereditary. Most hereditary ovarian cancer can be … Continue reading
Posted in Blog Leave a comment
NYC Jr. Committee Event: Fall Gala at Taj Lounge
WHAT: Drink specials, hors d’oeuvres, desserts, DJ, gift bags full of cosmetics, gourmet treats, product samples and more. Silent auction featuring vacation packages and gift certificates for restaurants, spas, sports and outdoor activities. $20 suggested donation at the door. WHERE: … Continue reading
Posted in Events Leave a comment
Carbo/Paclitaxel v. Carbo/PLD as first line treatment for Ovarian Cancer
A recently study evaluated standard first line therapy – carboplatin plus paclitaxel – against carboplatin plus Doxil (PLD). This study of more than 800 women found that the use of Doxil was not superior to standard therapy, although the women … Continue reading
Another Ovarian Cancer Vaccine Trial Approved
Sign Our Petition to End Ovarian Cancer Drug Shortages
Currently, there are more than 200 drug shortages in the United States. Many of these drugs are used to treat deadly diseases like ovarian cancer. These shortages have resulted in women with ovarian cancer not getting a drug their doctor … Continue reading
Posted in Blog Leave a comment
















